|
UBE3B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.066300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.586200E-01 |
| Normal-vs-Stage2 |
6.801200E-01 |
| Normal-vs-Stage3 |
7.959400E-01 |
| Normal-vs-Stage4 |
4.935000E-01 |
| Stage1-vs-Stage2 |
9.572000E-01 |
| Stage1-vs-Stage3 |
8.943600E-01 |
| Stage1-vs-Stage4 |
3.096400E-01 |
| Stage2-vs-Stage3 |
8.910800E-01 |
| Stage2-vs-Stage4 |
3.848600E-01 |
| Stage3-vs-Stage4 |
4.352800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.255770E-01 |
| Normal-vs-AfricanAmerican |
2.216200E-01 |
| Normal-vs-Asian |
5.781000E-01 |
| Caucasian-vs-AfricanAmerican |
8.057000E-01 |
| Caucasian-vs-Asian |
4.288000E-01 |
| AfricanAmerican-vs-Asian |
4.104000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.472500E-02 |
| Normal-vs-Female |
3.110000E-01 |
| Male-vs-Female |
7.341800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.477800E-01 |
| Normal-vs-Extreme_Weight |
7.802200E-01 |
| Normal-vs-Obese |
1.545390E-01 |
| Normal-vs-Extreme_Obese |
7.312200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.397200E-01 |
| Normal_Weight-vs-Obese |
1.816400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.433400E-01 |
| Extreme_Weight-vs-Obese |
1.473230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.841600E-01 |
| Obese-vs-Extreme_Obese |
7.300000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.995100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.817700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.883200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.181400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.063620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.267790E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.222110E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.138600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.229950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.331000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.775900E-04 |
| Normal-VS-Type2 PRCC |
3.761500E-02 |
| Normal-VS-KIRP CIMP |
1.800410E-01 |
| Normal-VS-Unclassified PRCC |
4.570200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.51970000000978E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.309900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.346800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.252400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.479200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.086100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.232400E-01 |
| Normal-vs-N1 |
6.174600E-01 |
| Normal-vs-N2 |
4.948400E-01 |
| N0-vs-N1 |
3.830000E-01 |
| N0-vs-N2 |
9.308000E-01 |
| N1-vs-N2 |
3.658800E-01 |
|
|
